Skip to content
Register Sign in Wishlist
Look Inside Club Drugs and Novel Psychoactive Substances

Club Drugs and Novel Psychoactive Substances
The Clinician's Handbook

$32.99 (M)

Owen Bowden-Jones; Dima Abdulrahim
View all contributors
  • Publication planned for: November 2020
  • availability: Not yet published - available from November 2020
  • format: Paperback
  • isbn: 9781911623090

$ 32.99 (M)

Pre-order Add to wishlist

Looking for an examination copy?

If you are interested in the title for your course we can consider offering an examination copy. To register your interest please contact providing details of the course you are teaching.

Product filter button
About the Authors
  • Over the last decade many hundreds of new psychoactive drugs have emerged onto illicit markets. This flood of new drugs has led to clinicians being unsure of the rapidly emerging changing evidence base and uncertain of the best approaches to assessment and clinical management. This book provides a concise, accessible summary of these emerging drugs. By categorizing the hundreds of new drugs by their predominant psychoactive effect - sedative, stimulant and hallucinogenic - the book helps clinicians to manage a drug they are unfamiliar with by using their experience of other drugs with similar psychoactive properties. Written for clinicians from across the frontline, from A&E staff to drug treatment professionals, the authors draw on numerous clinical examples from their own clinical experiences to illustrate aspects of assessment and management. Club drugs and novel psychoactive substances will continue to challenge clinicians and this handbook provides readers with an invaluable introduction to this complex area.

    • Categorizes the hundreds of new drugs according to their psychoactive effect - sedative, stimulant and hallucinogenic - allowing clinicians to orientate themselves to the huge number of newly emerging drugs by firstly identifying the predominant psychoactive effect and then using their experience of other drugs with similar effects to decide on the best treatment approach
    • Uses clinical examples from the authors' own practice, demonstrating the types of challenges clinicians may experience in their practices
    • Offers a clear division between acute harms and harms from persistent use, ensuring that clinicians from across the frontline, from A&E staff to those working in drug treatment, will find the book accessible
    Read more

    Reviews & endorsements

    'This book is an invaluable resource in a fast changing and baffling field of psychiatry. It provides an up-to-date, evidence-based guide by leading experts to all you need to know to provide care for those suffering the mental health consequences of novel psychoactive drugs.' Adrian James, President, Royal College of Psychiatrists

    'A very nice reading; very easy to follow and with a clear focus on the clinical issues, e.g. what the practicing clinician … need to know to interact with the client; to make a diagnosis; and identify a proper treatment and management approach. Although the language and the tones here used are straightforward and direct, the content of the document is precise, really updated, and definitely non-judgmental. I particularly enjoyed reading the clinical vignettes; they illustrate a range of complex issues in a way which is simple enough for even the non experienced clinician/non experienced trainee to be able to understand. There are a few sections, e.g. the one on psychedelic phenethylamines and GHB, which are of particular value. The focus on GHB withdrawal is important and detailed.' Fabrizio Schifano, Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, University of Hertfordshire

    See more reviews

    Customer reviews

    Not yet reviewed

    Be the first to review

    Review was not posted due to profanity


    , create a review

    (If you're not , sign out)

    Please enter the right captcha value
    Please enter a star rating.
    Your review must be a minimum of 12 words.

    How do you rate this item?


    Product details

    • Publication planned for: November 2020
    • format: Paperback
    • isbn: 9781911623090
    • copublisher: Royal College of Psychiatrists
    • dimensions: 186 x 122 x 7 mm
    • weight: 0.16kg
    • availability: Not yet published - available from November 2020
  • Table of Contents

    Part I:
    1. Introduction 2. What are NPS and Club Drugs and why are they important
    3. A brief history of NPS production and distribution
    4. Drugs classification framework for Club Drugs and NPS
    5. Clinical challenge of Club Drugs and NPS
    Part II. Stimulant Drugs
    6. Stimulant drugs: introduction
    7. Stimulant drugs: cocaine
    8. Stimulant drugs: amphetamine-type
    9. Stimulant drugs: methamphetamine
    10. Stimulant drugs: MDMA
    11. Stimulant drugs: synthetic cathinones
    Part III. Depressant Drugs
    12. Depressant drugs: introduction
    13. Depressant drugs: GHB/GBL
    14. Depressant drugs: Fentanyl, Fentanyl analogues and other opioid NPS
    15. Depressant drugs: Benzodiazepine NPS
    16. Depressant drugs: Ketamine and its anaologues
    Part IV. Synthetic Cannabinoid Receptor Agonsits
    17. Synthetic cannabinoid receptor agonists (SCRAs)
    Part V. Hallucinogens
    18. Hallucinogens
    Part VI. Concluding Remarks and References
    19. Concluding Remarks
    20. References.

  • Authors

    Owen Bowden-Jones, Central North West London NHS Foundation Trust
    Owen Bowden-Jones is Consultant in Addiction Psychiatry and Founder of the CNWL Club Drug Clinic, London, and Honorary Professor at University College London. He is Chair of the Advisory Council on the Misuse of Drugs and National Clinical Adviser to the Alcohol, Drugs and Tobacco division at Public Health England.

    Dima Abdulrahim, Central North West London NHS Foundation Trust
    Dima Abdulrahim is Programme Manager and Principal Researcher for the NEPTUNE Project for the Club Drug Clinic, Central and North West London NHS Foundation Trust. She has been working in the drug treatment field for over 30 years.


    Owen Bowden-Jones; Dima Abdulrahim

Sign In

Please sign in to access your account


Not already registered? Create an account now. ×

Sorry, this resource is locked

Please register or sign in to request access. If you are having problems accessing these resources please email

Register Sign in
Please note that this file is password protected. You will be asked to input your password on the next screen.

» Proceed

You are now leaving the Cambridge University Press website. Your eBook purchase and download will be completed by our partner Please see the permission section of the catalogue page for details of the print & copy limits on our eBooks.

Continue ×

Continue ×

Continue ×

Find content that relates to you

Join us online

This site uses cookies to improve your experience. Read more Close

Are you sure you want to delete your account?

This cannot be undone.


Thank you for your feedback which will help us improve our service.

If you requested a response, we will make sure to get back to you shortly.

Please fill in the required fields in your feedback submission.